Stocks Overview

LAST PRICE
34.0600
TODAY'S CHANGE (%)
Trending Up0.9900 (2.9936%)

Bid / Lots
33.5000/ 1
Ask / Lots
34.6800/ 6
Open / Previous Close
33.3500 / 33.0700
Day Range
Low 33.3500
High 34.2500
52 Week Range
Low 6.4000
High 47.4500
Volume
927,524
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 33.07
Time	Volume	DYN
09:32 ET	6612	33.54
09:34 ET	3652	33.74
09:36 ET	5462	33.79
09:38 ET	200	33.86
09:39 ET	100	33.64
09:41 ET	753	33.7
09:48 ET	100	33.49
09:50 ET	2417	33.7
09:52 ET	300	33.765
09:54 ET	1317	33.67
09:56 ET	34730	33.85
09:57 ET	875	33.895
09:59 ET	200	33.87
10:01 ET	1559	33.805
10:03 ET	200	33.88
10:06 ET	2300	33.77
10:08 ET	1000	33.76
10:10 ET	707	33.78
10:12 ET	100	33.82
10:14 ET	1349	33.83
10:15 ET	511	33.765
10:17 ET	1100	33.905
10:19 ET	500	33.93
10:21 ET	1574	33.9626
10:24 ET	800	33.97
10:26 ET	844	33.99
10:28 ET	1100	34.035
10:30 ET	300	34.025
10:32 ET	1716	33.945
10:33 ET	500	33.93
10:35 ET	264	33.921
10:37 ET	400	33.86
10:39 ET	2148	34.09
10:42 ET	400	34.25
10:44 ET	1000	34.105
10:46 ET	4546	34
10:48 ET	511	33.975
10:50 ET	700	33.99
10:51 ET	1450	34
10:53 ET	600	34.02
10:57 ET	3572	33.96
11:00 ET	1285	33.8806
11:02 ET	200	33.94
11:04 ET	700	33.99
11:06 ET	396	33.95
11:09 ET	2765	33.94
11:11 ET	147	33.945
11:13 ET	1251	33.94
11:15 ET	900	33.91
11:18 ET	1282	33.73
11:20 ET	1350	33.67
11:22 ET	3336	33.685
11:24 ET	1000	33.68
11:26 ET	4500	33.76
11:27 ET	300	33.8
11:29 ET	1200	33.925
11:31 ET	200	33.905
11:33 ET	300	33.96
11:36 ET	600	33.95
11:38 ET	75548	33.99
11:40 ET	2001	33.845
11:42 ET	1315	33.93
11:44 ET	400	33.91
11:45 ET	1000	33.815
11:47 ET	800	33.82
11:49 ET	1000	33.81
11:51 ET	1000	33.74
11:54 ET	4061	33.835
11:56 ET	100	33.86
11:58 ET	1700	33.8
12:00 ET	1320	33.86
12:02 ET	1394	33.83
12:03 ET	600	33.8
12:05 ET	2300	33.87
12:07 ET	1935	33.8
12:09 ET	700	33.83
12:12 ET	300	33.82
12:14 ET	1705	33.88
12:16 ET	2438	33.86
12:18 ET	2500	33.92
12:20 ET	809	33.9
12:21 ET	100	33.88
12:23 ET	737	33.89
12:25 ET	2528	33.92
12:27 ET	666	33.91
12:30 ET	400	33.9
12:32 ET	947	33.875
12:34 ET	2417	33.89
12:36 ET	400	33.86
12:38 ET	500	33.84
12:39 ET	900	33.85
12:41 ET	3000	33.915
12:43 ET	800	33.89
12:45 ET	200	33.825
12:48 ET	1102	33.78
12:50 ET	3103	33.85
12:52 ET	300	33.84
12:54 ET	200	33.81
12:56 ET	900	33.79
12:57 ET	1305	33.87
12:59 ET	300	33.9
01:01 ET	600	33.875
01:03 ET	1200	33.93
01:06 ET	2100	33.96
01:08 ET	1000	33.94
01:10 ET	1205	33.93
01:12 ET	729	33.93
01:14 ET	600	33.87
01:15 ET	1199	33.9
01:17 ET	800	33.9
01:19 ET	1490	33.98
01:21 ET	900	33.945
01:24 ET	300	33.93
01:26 ET	1508	33.94
01:28 ET	400	33.975
01:30 ET	600	33.93
01:32 ET	600	33.96
01:33 ET	892	33.96
01:35 ET	824	33.955
01:37 ET	200	33.94
01:39 ET	1045	33.93
01:42 ET	600	33.92
01:44 ET	700	33.9
01:46 ET	1000	33.96
01:48 ET	1300	33.91
01:50 ET	3450	33.88
01:53 ET	2137	33.865
01:55 ET	838	33.895
02:00 ET	400	33.83
02:02 ET	1417	33.76
02:04 ET	1913	33.82
02:08 ET	300	33.79
02:09 ET	600	33.785
02:11 ET	1300	33.785
02:13 ET	1999	33.71
02:15 ET	600	33.65
02:18 ET	2100	33.75
02:22 ET	1700	33.73
02:24 ET	900	33.7
02:26 ET	500	33.67
02:27 ET	2644	33.67
02:29 ET	800	33.655
02:31 ET	1248	33.66
02:33 ET	1891	33.67
02:36 ET	2085	33.71
02:38 ET	700	33.72
02:40 ET	300	33.73
02:42 ET	1535	33.77
02:44 ET	750	33.785
02:45 ET	900	33.75
02:47 ET	1260	33.75
02:49 ET	1100	33.77
02:51 ET	1592	33.695
02:54 ET	2800	33.7
02:56 ET	2202	33.76
02:58 ET	2079	33.765
03:00 ET	2700	33.71
03:02 ET	1700	33.72
03:03 ET	800	33.74
03:05 ET	6968	33.72
03:07 ET	3328	33.705
03:09 ET	1300	33.67
03:12 ET	1650	33.61
03:14 ET	1515	33.625
03:16 ET	2527	33.64
03:18 ET	2627	33.66
03:20 ET	1696	33.66
03:21 ET	3064	33.67
03:23 ET	2500	33.74
03:25 ET	1322	33.75
03:27 ET	2691	33.81
03:30 ET	2400	33.82
03:32 ET	3400	33.89
03:34 ET	300	33.93
03:36 ET	3338	33.955
03:38 ET	1649	33.87
03:39 ET	4601	33.845
03:41 ET	4831	33.88
03:43 ET	3199	33.82
03:45 ET	2700	33.78
03:48 ET	6018	33.89
03:50 ET	3666	33.89
03:52 ET	31959	33.92
03:54 ET	12497	33.94
03:56 ET	11078	33.96
03:57 ET	77066	34.02
03:59 ET	176074	34.06

Data delayed at least 15 minutes.

Yesterday
Sep 14, 2024
- An Investigation Has Been Launched Into Dyne Therapeutics Inc For Fraudulent Practices And Shareholders Can Assist The Schall Law Firm, from 11:01AM ET on Saturday Sep 14, 2024 by Dow Jones
  11:01AM ET on Saturday Sep 14, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesDYN Dyne Therapeutics Inc	3.4B	-9.5x	---
United StatesMLTX MoonLake Immunotherapeutics	3.3B	-56.6x	---
United StatesBHVN Biohaven Ltd	3.6B	-4.2x	---
United StatesIOVA Iovance Biotherapeutics Inc	3.1B	-6.1x	---
United StatesMRUS Merus NV	3.4B	-17.5x	---
United StatesXENE Xenon Pharmaceuticals Inc	3.1B	-14.9x	---
As of 2024-09-16

Dyne Therapeutics Inc. is a clinical-stage muscle disease company. It is focused on advancing life-transforming therapeutics for people living with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. Its FORCE platform therapeutics consist of an oligonucleotide payload that is designed to target the genetic basis of the disease. Using its FORCE platform, it is assembling a portfolio of muscle disease therapeutics, including its lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD), and facioscapulohumeral dystrophy (FSHD). Its therapeutics consist of three components: a Fab, a clinically validated linker, and an oligonucleotide payload that it attaches to its Fab using the linker. It also plans to expand its portfolio through development efforts focused on rare skeletal muscle diseases, as well as cardiac and metabolic muscle diseases.

Contact Information

Headquarters: 1560 Trapelo RoadWALTHAM, MA, United States 02451
Phone: 781-786-8230
Fax: 781-786-8866

Executives

Independent Chairman of the Board: Jason Rhodes
President, Chief Executive Officer, Director: John Cox
Chief Operating Officer: Susanna High
Chief Human Resource Officer: Lucia Celona
Senior Vice President, Head of Finance and Administration: Richard Scalzo

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$3.4B
Revenue (TTM)	$0.00
Shares Outstanding	100.4M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.11
EPS	$-3.58
Book Value	$1.49
P/E Ratio	-9.5x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Dyne Therapeutics Inc
NASDAQ:DYNUnited States

Search Criteria

Charts

Recent News

Yesterday

DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm!, from 9 hours ago by Dow Jones

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN, from 13 hours ago by Dow Jones

The Schall Law Firm Is Looking Into Dyne Therapeutics, Inc. For Violating Securities Laws And The Firm Invites Investor Participation, from 14 hours ago by Dow Jones

Bronstein, Gewirtz & Grossman, LLC Encourages Dyne Therapeutics, Inc. (DYN) Stockholders to Inquire about Securities Investigation, from 15 hours ago by Dow Jones

Sep 14, 2024

An Investigation Has Been Launched Into Dyne Therapeutics Inc For Fraudulent Practices And Shareholders Can Assist The Schall Law Firm, from 11:01AM ET on Saturday Sep 14, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar